Dapsone as an oral corticosteroid sparing agent for asthma
Sübutlu məlumatların xülasələri
13.07.2017 • Sonuncu dəyişiklik 13.07.2017
Editors
There is no evidence from randomized controlled trials of dapsone for steroid-dependent asthmatic patients.
A Cochrane review found no trials that met the selection criteria. An update search conducted in February 2009 did not identify any new references for inclusion in the review.
Ədəbiyyat
- Dewey A, Bara A, Dean T, Walters H. Dapsone as an oral corticosteroid sparing agent for asthma. Cochrane Database Syst Rev 2002;(4):CD003268 [Review content assessed as up-to-date: 12 February 2009].